Editor-in-Chief:

Mark A. Babizhayev
Innovative Vision Products, Inc.
County of New Castle, Delaware
USA



Associate Editors:

Ryan Donnelly
School of Pharmacy
Queen's University Belfast
Belfast
UK


Brahma N. Singh
Product Development Group
Forest Research Institute, Inc.
New York 11725
USA


Regional Editors:

George Voyiatzis
Foundation for Research and Technology
Inst. of Chemical Engineering 
FORTH/ICE-HT
Rio-Patras 
Greece


Tsutomu Yasukawa 
Department of Ophthalmology and Visual Science
Nagoya City University 
Nagoya 
Japan


Guest Editors:

Recent Patents On Stem Cell And Biomedical Applications
Sabata Martino
Biochemistry and Molecular Biology University of Perugia Via del
Giochetto
Perugia

Chronopharmaceuticals-A New Frontier in Pharmaceutics
Anil K. Philip
University of Nizwa,
Nizwa
Oman



Editorial Advisory Board:

F. Acarturk (Gazi University, Ankara, Turkey)
A. Agrawal (Dyodelta Biosciences Ltd., Cambridgeshire, UK)
F. Ahmed (Jamia Hamdard, New Delhi, India)
C. Allen (University of Toronto, Toronto, Canada)
A.I. Alvarez (University of Leon Campus Vegazana, Leon, Spain)
M. Amiji (Northeastern University, Boston, MA, USA)
B.G. Amsden (Queen's Univ., Kingston, ON, Canada)
A.G. Asuero (The University of Seville, Seville, Spain)
T. Baczek (Medical University of Gdansk, Gdansk, Poland)
M.B. Bally (British Columbia Cancer Agency, Vancouver, BC, Canada)
A.K. Banga (Mercer University, Atlanta, GA, USA)
A.K. Bansal (Nat. Inst. Pharmaceutical Edu and Res, Mohali, India)
E.H. Barash (Chief Patent Counsel, West Lafayette, IN, USA)
E. Bilensoy (Hacettepe University, Ankara, Turkey)
G. Bonora (Università di Trieste,Trieste, Italy)
D. Borchman (University of Louisville, Louisville, KY, USA)
M. Bourin (Universite de Nantes, Cedex, France)
S. Brocchini (University of London, London, UK)
M. Brunner (Medical Univ. of Vienna, Vienna, Austria)
G. Buckton (University of London, London, UK)
F.J. Burczynski (University of Manitoba, Manitoba, Canada)
N. Çelebi (Gazi University, Ankara, Turkey)
M. Cemazar (Institute of Oncology, Ljubljana, Solvenia)
H.K. Chan (University of Sydney, Sydney, Australia)
Y.E. Choonara (University of the Witwatersrand, Johannesburg, South Africa)
P. Colombo (Parco Area delle Scienze, Parma, Italy)
P.P. Constantinides (Biopharmaceutical & Drug Delivery Consulting, LLC, IL, USA)
R. Conti (Univ.of Pavia, Pavia, Italy)
T. Coviello (Universita La Sapienza, Rome, Italy)
C. Davidson (Davidson, Davidson & Kappel, LLC, New York, NY, USA)
E. di Luccio (Kyungpook National University, Daegu, South Korea)
M.G. Dodov (Institute of Pharmaceutical Technology, Skopje, Macedonia)
T. Ehtezazi (Liverpool John Moores University, Liverpool, UK)
A.O.S. El-Kadi (Univ.of Alberta, Alberta, AB, Canada)
M.L. Elsae (University of Miami Miller, Miami, FL, USA)
J.-Y. Fang (Chang Gung Univ., Taoyuan, Taiwan)
B. Finnin (Monash University, Parkville, Australia)
R. Gaudana (Par Pharmaceutical Companies, Inc., Spring Valley, NY, USA)
R.A. Gemeinhart (The University of Illinois, Chicago, IL, USA)
M.C. Gohel (L. M. College of Pharmacy, Ahmedabad, India)
G. Golomb (The Hebrew Univ.of Jerusalem, Jerusalem, Israel)
L. González-Mariscal (Center for Res. and Adv. Studies, México, Mexico)
K. Goracinova (University of Sts Cyril and Methodius, Skopje, Macedonia)
H. Gupta (University of Colorado, Aurora, CO, USA)
H. Harashima (Hokkaido University, Hokkaido, Japan)
P. Hiremath (Pharmaceutics International Inc., Cockeysville, MD, USA)
K.R. Jadhav (Bharati Vidyapeeths Coll.of Pharmacy, Mumbai, India)
S. Jain (Nat. Inst. Pharmaceutical Edu and Res, Mohali, India)
Y. Kost (Ben Gurion University of the Negev, Beer Sheva, Israel)
G.S. Kwon (University of Wisconsin, Madison, WI, USA)
A.G. Lacko (University of North Texas Health Science Center,Texas, TX, USA)
A. Lamprecht (Univ.of Franche-Comté, France)
B. Lebleu (CNRS, Paris, France)
B.-J. Lee (Kangwon National University, Chuncheon, Korea)
H. Lennernas (Uppsala Univ., Uppsala, Sweden)
A.A. Linninger (The University of Illinois, Chicago, IL, USA)
J. Lisziewicz (The Therapeutic Vaccine Company, Washington, WA, USA)
Y. Maitani (Hoshi University, Tokyo, Japan)
H.M. Mansour (The University of Arizona-Tucson, Tucson, AZ, USA)
A. Mehta (Mumbai University, Mumbai, India)
B.B. Michniak-Kohn (The State University of NJ, Piscataway, NJ, USA)
X. Ming (University of North Carolina at Chapel Hill, Chapel Hill, NC, USA)
T. Minko (The State University of New Jersey, Piscataway, NJ, USA)
P.R. Mishra (Central Drug Research Institute, Lucknow, India)
A. Misra (The Maharaja Sayajirao Univ. of Baroda, Vadodara, India)
A.K. Mitra (Univ.of Missouri-Kansas City, Kansas City, MO, USA)
S. Moghimi (University of Brighton, Brighton, UK)
M. Morishita (Hoshi Univ., Tokyo, Japan)
R.I. Moustafine (Kazan State Medical University, Kazan, Russian Federation)
L. Mu (Division of Toxicology, Laurel, MD, USA)
A.S. Mundada (S.S.D.J. College of Pharmacy, Maharashtra, India)
S.N. Murthy (The Univ. of Mississippi, Oxford, MS, USA)
R.J. Neufeld (Queen’s University Kingston, Ontario, K7L 3N6, Canada)
Y. Obata (Hoshi University, Tokyo, Japan)
M. Ogris (Ludwig-Maximilians-Universitat, Munich, Germany)
A. Omri (Laurentian University,Ontario, ON, Canada)
Y. Perrie (Aston University, Birmingham, UK)
V. Pillay (University of the Witwatersrand, Johannesburg, South Africa)
T. Potta (Arizona State University, Tempe, AZ, USA)
D. Quintanar-Guerrero (Universidad Nacional Autónoma de México, State of Mexico, Mexico)
R.L. Remmele (Amgen Inc., Thousand Oaks, CA, USA)
V.A. Saharan (Institute of Pharmaceutical Sciences and Drug Research, Rajasthan, India)
D.K. Sarker (The University of Brighton, Brighton, UK)
R.M. Schiffelers (Utrecht Inst. for Pharmaceut. Sciences, Utrecht, Netherlands)
J. Singh (North Dakota State Univ., Fargo, ND, USA)
M.K. Singh (Dabur Research Foundation, Pune, India)
M. Singh (Chiron Corporation, Emeryville, CA, USA)
P.J. Sinko (The State Univ. of New Jersey, New Jersey, NJ, USA)
A. Sintov (Ben-Gurion University of the Negev , Beer-Sheva, Israel)
G. Smaldone (State Univ. of New York at Stony Brook, New York, NY, USA)
J. Smart (University of Brighton, Brighton, UK)
E.B. Souto (Fernando Pessoa University, Porto, Portugal)
S. Srcic (Univ.of Ljubljana, Ljubljana, Slovenia)
B. Steffansen (University of Copenhagen, Copenhagen, Denmark)
S. Svenson (Dendritic NanoTechnologies Inc., Mount Pleasant, MI , USA)
S. Talegaonkar (Jamia Hamdard, New Delhi, India)
Y. Tang (Novartis, Cambridge, MA, USA)
A.K. Tiwary (Punjabi University, Patiala, India)
A.G. Thombre (Pfizer Inc,Groton, CT, USA)
G. Trapani (University of Bari, Bari, Italy)
S. Tommasi (National Cancer Centre, Bari, Italy)
V.P. Torchilin (Northeastern Univ., Boston, MA, USA)
M.L. Torre (Univ. of Pavia, Pavia, Italy)
I. Toth (University of Queensland, Brisbane, Australia)
E. Touitou (The Hebrew University of Jerusalem, Jerusalem, Israel)
I.F. Uchegbu (Univ.of London, School of Pharmacy, UK)
N. Udupa (Manipal College of Pharmaceutical Sciences, Manipal, India)
G. van den Mooter (Katholieke Univ. Leuven, Leuven, Belgium)
S. Venkatraman (School of Materials Sci. & Eng., Singapore)
H. Viernstein (University of Vienna, Vienna, Austria)
S.P. Vyas (Dr. Harisingh Gour Univ., Sagar, India)
K. Yamasaki (Sojo University, Kumamoto, Japan)